首页> 外文期刊>Cancer Informatics >Trial Prospector: Matching Patients with Cancer Research Studies Using an Automated and Scalable Approach
【24h】

Trial Prospector: Matching Patients with Cancer Research Studies Using an Automated and Scalable Approach

机译:试用者:使用自动且可扩展的方法为癌症研究患者匹配

获取原文
           

摘要

Cancer is responsible for approximately 7.6 million deaths per year worldwide. A 2012 survey in the United Kingdom found dramatic improvement in survival rates for childhood cancer because of increased participation in clinical trials. Unfortunately, overall patient participation in cancer clinical studies is low. A key logistical barrier to patient and physician participation is the time required for identification of appropriate clinical trials for individual patients. We introduce the Trial Prospector tool that supports end-to-end management of cancer clinical trial recruitment workflow with (a) structured entry of trial eligibility criteria, (b) automated extraction of patient data from multiple sources, (c) a scalable matching algorithm, and (d) interactive user interface (UI) for physicians with both matching results and a detailed explanation of causes for ineligibility of available trials. We report the results from deployment of Trial Prospector at the National Cancer Institute (NCI)-designated Case Comprehensive Cancer Center (Case CCC) with 1,367 clinical trial eligibility evaluations performed with 100% accuracy.
机译:全世界每年约有760万人死于癌症。 2012年在英国进行的一项调查发现,由于参与临床试验的人数增加,儿童癌症的存活率有了显着提高。不幸的是,患者对癌症临床研究的总体参与度很低。病人和医师参与的主要后勤障碍是为个别病人确定适当的临床试验所需的时间。我们引入了Trial Prospector工具,该工具通过以下方式支持癌症临床试验招募工作流程的端到端管理:(a)试验资格标准的结构化输入;(b)从多个来源自动提取患者数据;(c)可扩展的匹配算法,以及(d)面向医生的交互式用户界面(UI),具有匹配的结果以及对现有试验不合格的原因的详细说明。我们报告了在美国国家癌症研究所(NCI)指定的案例综合癌症中心(Case CCC)部署Trial Prospector的结果,并以100%的准确性进行了1,367项临床试验资格评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号